title: Sequential proleukin(rIL-2) by continuous infusion with cisplatin and cyclophosphamide in patients with unresectable ovarian cancer.
authors.forename: R P
authors.initials: RP
authors.lastname: de Dycker
authors.forename: R L
authors.initials: RL
authors.lastname: Neumann
authors.forename: T
authors.initials: T
authors.lastname: Schumacher
authors.forename: U
authors.initials: U
authors.lastname: Heckmann
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D010051:Ovarian Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000009:adverse effects
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins